Lidocaine in the horse: Its pharmacological effects and their relationship to analytical findings

Journal of Veterinary Pharmacology and Therapeutics

Volumn 21, Issue 6, 1998, Pages 462-476

  Harkins, J Daniel ^a   Mundy, G D ^b   Woods, W E ^a   Lehner, A ^a   Karpiesiuk, W ^a   Rees, W A ^a   Dirikolu, L ^a   Bass, S ^c   Carter, W G ^a   Boyles, J ^a   Tobin, T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Kentucky Racing Commission   (United States)

^c Neogen Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG BLOOD LEVEL; DRUG URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; URINALYSIS;

ANESTHETICS, LOCAL; ANIMALS; CHROMATOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HORSES; INJECTIONS, SUBCUTANEOUS; LIDOCAINE; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0032425344     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1998.00165.x     Document Type: Article

References (22)

1. Agriculture Canada (1991) Race Track Division Schedule of Drugs. Ontario Agriculture Canada, Ottowa.
2. Australian Equine Veterinary Association (1992) Detection of Substances in Racing Horses. Australian Equine Veterinary Association, Artarmon, Australia.
3. Chalmers, P., Elgar, D., Blay, P., Teale, P. & Moss, M.S. (1987) Lidocaine: Metabolism and urinary excretion by the horse. In Proceedings of the 6th International Conference of Racing Analysts and Veterinarians. Ed. Crone, D.L. pp. 217-222. MacMillan Publishing, Hong Kong.
4. Combie. J., Blake, J.W., Nugent, E. & Tobin, T. (1982) Morphine glucuronide hydrolysis: Superiority of B-glucuronidase from Patella vulgata. Clinical Chemistry, 28, 83-86.
5. Day, T.K. & Skarda, R.T. (1991) The pharmacology of local anesthetics. In Veterinary Clinics of North America. Ed. A. L. Bertone. pp. 489-500. Equine Practice, 7.
6. Early, R.J., Thompson, J.R., Sedgewick, G.W., Kelly, J.M. & Christopherson, K.J. (1987) Capillary gas chromatographic analysis of amino acids in blood and protein hydrolysates as tert-butlydimethylsilyl deravatives. Journal of Chromatography, 416, 15-23.
7. European Horserace Scientific Liaison Committee (1997) Information for Veterinary Surgeons on Detection Periods of Named Drugs. R & W Publications Limited. Newmarket, UK.
8. Gerken, D.F., Sams, R.A., McKeever, K.H., Hinchcliff, K.W. & Ashcraft, S. (1991) Urinary pH effects on the renal clearance of lidocaine and phenylbutazone in exercising horses. The Toxicologist, p. 297 (Abstract).
9. Harkins, J.D., Mundy, G.D., Stanley, S., Woods, W.E., Rees, W.A., Thompson, K.N. & Tobin, T. (1996) Determination of highest no-effect dose (HNED) for local anesthetic responses to procaine, cocaine, bupivacaine, and benzocaine. Equine Veterinary Journal, 28, 30-37.
10. Karnes, H.T., Shiu, G. & Shah, V.P. (1991) Validation of Bioanalytical methods. Pharmaceutical Research, 8, 421-426.
11. Klee, M.S. (1990) GC Inlets - An Introduction, pp. 7-21. Hewlett Packard Co., Avondale, PA.
12. Norwood, G. (1995) American Association of Equine Practitioners Therapeutic Medication List. In Proceedings from 'Testing for Therapeutic
13. Medications, Environmental and Dietary Substances in Racing Horses' Eds Tobin, T., Mundy, G.D. Stanley, S.D., Sams, R.A. & Crone, D.L. pp. 191-192. The Maxwell H. Gluck Equine Research Center. Lexington, KY.
14. QAP Committee (1995) Policy on analytical testing of the therapeutic substances approved by RCI board. Association of Racing Commissioners International QAP Newsletter, May 19.
15. Sams, H.A. (1997) Pharmacokinetic studies of drugs in racehorses. Proceedings of the International Conference of Racing Analyst and Veterinarians, 11, 545-554.
16. Shah, V.P., Midha, K.K., Shrikant, D., McGilveray. I.J., Skelly, J.P., Yacobi, A., Layloff, T., Viswanathan, C.T., Cook, C.E., McDowall, R.D., Pittman, K.A. & Spector, S. (1992) Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. Journal of Pharmaceutical Sciences, 81, 309-512.
17. Short, C.R., Flory, W., Hsieh, L.C., Aranas, T. & Barker, S.A. (1988) Metabolism and urinary elimination of lidocaine in the horse. In Proceedings of the 7th International Conference of Racing Analysts and Veterinarians. Eds Tobin, T., Blake, J., Potter, M. & Wood, T. pp. 323-329. ICRAV, Lexington, KY.
18. Thomas, J. & Meffin, P. (1972) Aromatic hydroxylation of lidocaine and mepivacaine in rats and humans. Journal of Medicine and Chemistry, 15, 1046-1049.
19. Tobin, T. (1981) Drugs and the Performance Horse, pp. 459-145. Charles C. Thomas, Springfield, IL.
20. Tobin, T. (1995) Thresholds/Limits on Testing for Therapeutic Medications: Viewpoints of the Regulated. In Testing for Therapeutic Medications. Environmental and Dietary Substances in Racing Horses. Eds Tobin, T., Mundy, G.D., Stanley, S.D., Sams, R.A. & Crone, D.L., pp. 23-32. The Maxwell H. Gluck Equine Research Center, Lexington, KY.
21. Tobin, T., Blake, J.W., Sturma, L., Arnett, S. & Truelove, J. (1977) Pharmacology of procaine in the horse: pharmacokinetics and behavioural effects. American Journal of Veterinary Research, 38, 637-647.
22. Voller, A., Bidwell, D.W. & Bartlett, A. (1976) The enzyme linked immunosorbent assay (ELISA). Bulletin of the World Health Organization, 53, 55-56.